The Need for an Iterative Process for Assessing Economic Outcomes Associated with SSRIs Tracy L. SkaerDavid A. SclarRichard S. Galin Current Opinion 27 October 2012 Pages: 205 - 214
The Epidemic of Alzheimer’s Disease Neil JohnsonTim DavisNick Bosanquet Review Article 27 October 2012 Pages: 215 - 223
Costs of Deep Foot Infections in Patients with Diabetes Mellitus Gunnel Ragnarson TennvallJan ApelqvistMagnus Eneroth Original Research Article 27 October 2012 Pages: 225 - 238
Cost-Effectiveness Model of Cytomegalovirus Management Strategies in Renal Transplantation Josephine A. MauskopfAnke RichterGrant Maclaine Original Research Article 27 October 2012 Pages: 239 - 251
Cost Implications for the Use of Inhaled Anti-Inflammatory Medications in the Treatment of Asthma Ronald J. OzminkowskiShaohung WangDavid Schutt Original Research Article 27 October 2012 Pages: 253 - 264
Cost Effectiveness of Abciximab During Routine Medical Practice Shelby Ogilvie ReedC. Daniel MullinsLaurence S. Magder Original Research Article 27 October 2012 Pages: 265 - 274
The Economic Value of a New Insulin Preparation, Humalog® Mix 25™ George DranitsarisChristopher J. LongoLoren D. Grossman Original Research Article 27 October 2012 Pages: 275 - 287
Glipizide Rachel H. FosterGreg L. Plosker Adis Pharmacoeconomic Drug Evaluation 27 October 2012 Pages: 289 - 306